ACHV
Achieve Life Sciences Inc
NASDAQ: ACHV · HEALTHCARE · BIOTECHNOLOGY
$4.15
-2.81% today
Updated 2026-04-29
Market cap
$220.95M
P/E ratio
—
P/S ratio
5.09x
EPS (TTM)
$-1.25
Dividend yield
—
52W range
$2 – $6
Volume
1.1M
Achieve Life Sciences Inc (ACHV) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.39M | $20.13M | $20.13M | $25.54M | $13.62M | $5.50M | $20.09M | $29.88M | $27.12M | $18.16M | $5.06M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | -10.1% | +0.0% | +26.9% | -46.7% | -59.6% | +265.6% | +48.7% | -9.3% | -33.0% | -72.1% | -100.0% | — | — | — | — | — | — | — | — |
| Cost of revenue | $7.97M | $4.14M | $7.82M | $20.21M | $18.48M | $21.55M | $39.95M | $0.00 | $0.00 | $0.00 | $0.00 | $282000.00 | $282000.00 | $254000.00 | $255000.00 | $250000.00 | $236000.00 | $228000.00 | $229000.00 | $228000.00 |
| Gross profit | $22.39M | $20.13M | $20.13M | $25.54M | $13.62M | $5.50M | $20.09M | $29.88M | $27.12M | $18.16M | $5.06M | $-282000.00 | $-282000.00 | $-254000.00 | $-255000.00 | $-250000.00 | $-236000.00 | $-228000.00 | $-229000.00 | $-228000.00 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — | — | — | — | — | — | — | — | — |
| R&D | $41.10M | $27.15M | $7.82M | $24.16M | $18.48M | $21.55M | $39.95M | $55.32M | $46.22M | $25.11M | $14.79M | $3.10M | $5.87M | $9.67M | $6.88M | $23.97M | $30.08M | $15.81M | $22.82M | $22.96M |
| SG&A | $7.58B | $8.22B | $3.29M | $3.96M | $5.84M | $6.23M | $7.79M | $9.89M | $10.63M | $11.80M | $8.93M | $3.53M | $6.95M | $6.85M | $7.87M | $9.13M | $10.72M | $11.44M | $16.25M | $31.87M |
| Operating income | $-26.29M | $-15.23M | $-6.26M | $-2.46M | $-14.74M | $-22.29M | $-25.99M | $-35.33M | $-29.47M | $-18.75M | $-21.19M | $-6.63M | $-12.81M | $-16.53M | $-14.75M | $-33.09M | $-40.80M | $-27.25M | $-39.07M | $-54.88M |
| Operating margin | -117.4% | -75.7% | -31.1% | -9.7% | -108.3% | -405.5% | -129.3% | -118.2% | -108.7% | -103.3% | -418.6% | — | — | — | — | — | — | — | — | — |
| EBITDA | $-22.94M | $-12.41M | $-10.60M | $1.42M | $-15.53M | $-22.21M | $-21.00M | $-31.62M | $-26.02M | $-18.51M | $-19.94M | $-13.35M | $-12.53M | $-16.27M | $-14.47M | $-32.84M | $-40.56M | $-26.73M | $-37.42M | $-54.65M |
| EBITDA margin | -102.4% | -61.6% | -52.7% | 5.6% | -114.1% | -404.1% | -104.5% | -105.8% | -95.9% | -101.9% | -393.9% | — | — | — | — | — | — | — | — | — |
| EBIT | $-23.55M | $-13.06M | $-10.69M | $1.37M | $-15.58M | $-22.29M | $-21.10M | $-31.85M | $-26.24M | $-18.75M | $-20.13M | $-13.63M | $-12.81M | $-16.53M | $-14.73M | $-33.09M | $-40.80M | $-26.96M | $-37.65M | $-54.88M |
| Interest expense | $2984.00 | $434.00 | $0.00 | $0.00 | $1.03M | $0.00 | $0.00 | $0.00 | $531000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $69000.00 | $17000.00 | $1.79M | $2.85M | $2.18M | $819000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-23.55M | $-13.06M | $-4.20M | $5.48M | $-12.58M | $-14.67M | $-21.10M | $-31.85M | $-26.24M | $-16.80M | $-20.13M | $-10.58M | $-12.69M | $-16.14M | $-14.66M | $-32.90M | $-41.88M | $-29.82M | $-39.83M | $-54.65M |
| Net income growth (YoY) | — | +44.5% | +67.8% | +230.3% | -329.8% | -16.6% | -43.8% | -51.0% | +17.6% | +36.0% | -19.8% | +47.4% | -19.9% | -27.2% | +9.2% | -124.4% | -27.3% | +28.8% | -33.6% | -37.2% |
| Profit margin | -105.2% | -64.9% | -20.9% | 21.4% | -92.4% | -267.0% | -105.0% | -106.6% | -96.8% | -92.5% | -397.6% | — | — | — | — | — | — | — | — | — |